Milestone Gallery
Milestone Overview
Genetic screening AI innovation at SPIHF
During the 2021 St. Petersburg International Health Forum, the Founder and CEO of iPavlov presented a clinical decision support system designed to accelerate the detection of rare genetic conditions. This milestone highlights a shift in diagnostic methodology, moving from manual chart review to automated pattern recognition within electronic medical records.
Optimizing rare disease diagnostics
The deployed iPavlov Smart Clinic Platform utilizes neural networks to analyze patient history and clinical markers. By automating the screening process, the system allows medical organizations to process patient data at unprecedented speeds.
Impact Target: The implementation of automated diagnostic screening aims to reduce the time required to confirm a rare disease diagnosis from seven years to two, with a projected 50 percent reduction in childhood mortality rates.
Technical scope of the screening system
The diagnostic capabilities of the platform extend to several critical genetic disorders where early intervention is paramount. The system currently targets the identification of the following conditions:
Mucopolysaccharidosis type I
Fabry disease
Pompe disease
Acid sphingomyelinase deficiency
The ability to analyze vast archives of anonymized patient data transforms how we identify high-risk groups. Our goal is to augment the expert physician's workflow by providing faster, evidence-based indicators for conditions that have historically taken years to diagnose.
Expanding the diagnostic framework
This development represents a significant advancement for the enterprise transformation portfolio. By integrating AI-driven analysis into standard clinical environments, the methodology establishes a scalable framework for future disease tracking. The project demonstrates how advanced computation can bridge gaps in pediatric care, ensuring that vital health records serve as active instruments for proactive medical management.